Free tool
FAERS Monitor: Glumetza
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021748 or its brand name (Glumetza, Metformin Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
60,186
Serious
43,694
73% of reports
Hospitalization
23,541
Death reported
5,792
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- lactic acidosis4,572
- diarrhoea4,532
- nausea3,677
- acute kidney injury3,336
- fatigue3,257
- drug ineffective2,883
- vomiting2,741
- dyspnoea2,732
- headache2,423
- off label use2,267
- dizziness2,240
- asthenia2,181
- pain2,163
- fall1,984
- malaise1,860
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 94 |
| 2005 | 133 |
| 2006 | 408 |
| 2007 | 284 |
| 2008 | 441 |
| 2009 | 676 |
| 2010 | 984 |
| 2011 | 950 |
| 2012 | 1,968 |
| 2013 | 896 |
| 2014 | 967 |
| 2015 | 1,954 |
| 2016 | 2,273 |
| 2017 | 2,672 |
| 2018 | 3,943 |
| 2019 | 3,228 |
| 2020 | 2,817 |
| 2021 | 3,533 |
| 2022 | 6,432 |
| 2023 | 6,369 |
| 2024 | 6,922 |
| 2025 | 7,079 |
| 2026 | 5,161 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,993,973 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| lactic acidosisSignal | 4,572 | 57.3 | 55.6 | 217,398 |
| acute kidney injurySignal | 3,336 | 7.8 | 7.5 | 19,369 |
| diarrhoeaSignal | 4,532 | 2.5 | 2.4 | 4,036 |
| fallSignal | 1,984 | 2.1 | 2.0 | 1,138 |
| vomitingSignal | 2,741 | 2.0 | 2.0 | 1,484 |
| astheniaSignal | 2,181 | 2.0 | 2.0 | 1,158 |
| dyspnoea | 2,732 | 1.7 | 1.6 | 786 |
| nausea | 3,677 | 1.6 | 1.6 | 917 |
| dizziness | 2,240 | 1.6 | 1.5 | 475 |
| malaise | 1,860 | 1.5 | 1.4 | 298 |
| fatigue | 3,257 | 1.5 | 1.4 | 495 |
| headache | 2,423 | 1.4 | 1.3 | 228 |
| pain | 2,163 | 1.2 | 1.2 | 96 |
| off label use | 2,267 | 0.9 | 0.9 | 24 |
| drug ineffective | 2,883 | 0.8 | 0.7 | 224 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.